TRIALS OF THE BRONCHODILATOR ACTIVITY OF THE ISOENZYME-SELECTIVE PHOSPHODIESTERASE INHIBITOR AH 21-132 IN HEALTHY-VOLUNTEERS DURING A METHACHOLINE CHALLENGE TEST

被引:37
作者
FOSTER, RW
RAKSHI, K
CARPENTER, JR
SMALL, RC
机构
[1] Department of Physiological Sciences, Medical School, University of Manchester
关键词
AH; 21-132; BRONCHODILATORS; METHACHOLINE; NORMAL HUMAN SUBJECTS; SUCROSE;
D O I
10.1111/j.1365-2125.1992.tb05658.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 An approximately steady-state reduction of specific airway conductance was induced in normal human subjects by means of a methacholine individualized loading + maintenance dose regime. Tested against this background bronchoconstriction, the mixed type III/IV phosphodiesterase inhibitor AH 21-132, ingested in doses up to 90 mg, had no detectable bronchodilator activity. 2 AH 21-132, infused intravenously over 15 min, evoked short-lived bronchodilatation at doses of 20 and 40 mg, without affecting blood pressure or heart rate. 3 AH 21-132, mixed 1:18.5 by weight with sucrose, dissolved in saline, nebulized and inhaled in doses between 2 and 24 mg of AH 21-132, produced dose-dependent bronchodilatation. The ED50 was estimated as 9.2 mg AH 21-132. The peak relief of imposed bronchoconstriction was 80% and the apparent half-time of removal of AH 21-132 from its site of action was 25 min. 4 Inhaled, nebulized, hypertonic sucrose had a minor bronchodilator action. 5 AH 21-132, by intravenous and inhaled routes of administration, provides relief of methacholine-induced bronchoconstriction.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 20 条
[1]  
BERRY J L, 1989, British Journal of Pharmacology, V97, p446P
[2]  
BEWLEY JS, 1988, BRIT J PHARMACOL, V93, pP52
[3]  
BOYLE J P, 1989, British Journal of Pharmacology, V96, p54P
[4]  
Elliott K R, 1991, J Enzyme Inhib, V4, P245, DOI 10.3109/14756369109035848
[5]   A METHOD FOR BIOASSAY OF POTENCY AND EFFECTIVENESS OF INHALED BRONCHODILATORS IN NORMAL SUBJECTS [J].
FOSTER, RW ;
ATANGA, GK ;
CARPENTER, JR ;
EVANS, DE ;
RAKSHI, K ;
SMALL, RC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :445-455
[6]  
FOSTER RW, 1990, EUR RESP J S10, V3, pS97
[7]  
FOSTER RW, 1990, BRIT J PHARMACOL, V99, pP193
[8]  
GIEMBYCZ M A, 1989, British Journal of Pharmacology, V97, p559P
[9]   BIOCHEMICAL AND PHARMACOLOGICAL INTERACTIONS BETWEEN THE PAPAVERINE DERIVATIVE, AH 21-132, AND METHACHOLINE IN BOVINE TRACHEAL SMOOTH-MUSCLE [J].
GIEMBYCZ, MA ;
CHILVERS, ER ;
BARNES, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) :2157-2158
[10]   SELECTIVE-INHIBITION OF A HIGH-AFFINITY TYPE-IV CYCLIC-AMP PHOSPHODIESTERASE IN BOVINE TRACHEALIS BY AH 21-132 - RELEVANCE TO THE SPASMOLYTIC AND ANTI-SPASMOGENIC ACTIONS OF AH 21-132 IN THE INTACT TISSUE [J].
GIEMBYCZ, MA ;
BARNES, PJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (03) :663-677